Mary R. Gilhuly ’91 has been named for her distinguished service by CTCPA Women, an award program celebrating Connecticut’s exceptional CPAs.  The award was presented at the CTCPA Women’s Awards Breakfast.  Ms. Gilhuly is the EVP and CFO of Community Mental Health Affiliates, Inc.

John Toscano ’91 has been appointed as a partner with Blum Shapiro, the largest regional business advisory firm based in New England.  As a partner, he will be participating in the leadership of Blum’s Education Practice.

Donald L. Anderson, Jr. ’99 is currently the Senior Vice President & CIO, Federal Reserve Bank of Boston and has been named to the Board of Directors of Wall Street Technology Association(WSTA©), an industry organization that provides technology and business professionals in the financial industry a forum to learn from and connect with each other.

Joseph D. Bruhin ’87, ’92 MBA has been appointed Senior Vice President & Chief Information Officer of Breakthru Beverage.  Mr. Bruhin will serve on Breakthru’s Executive Leadership Team and oversee the implementation and execution of a holistic IT Strategic Plan.

Eric R. Judge ’87, ’92 MBA is currently a Financial Advisor at Edward Jones and has just published Out of Town Landlord – Lessons Learned During the Great Recession.  His book is available for purchase from Amazon:  https://www.amazon.com/Out-Town-Landlord-Lessons-Recession/dp/1641113782.

Kevin E. Burke ’95 MBA has been named by Southern Connecticut State University School of Business to its Business Advisory Council.  Mr. Burke is a senior vice president and market executive for Wells Fargo commercial banking in the Connecticut and New York Capital Region.

 

Ronald O. Rosenberg ’93 MBA has been appointed Group Technical Innovation Director of Azelis.  Mr. Rosenberg’s key role covers group’s strategy and direction for innovation, leadership for the Azelis lab community, and optimization and harmonization of Azelis’s 60 labs across the globe.

Scott E. Szymanski ’98 MBA has been named President of Theranica USA, headquartered in Montclair, NJ.  Mr. Szymanski will help lead the launch of FDA-cleared Nerivio for acute treatment of migraines.